美国食品和药物管理局批准Alembic的通用甲状腺素注射用于癌症和自身免疫治疗. FDA approves Alembic's generic methotrexate injection for cancer and autoimmune treatments.

美国食品和药物管理局已经批准了Alembic制药的一般甲醇注射. Alembic Pharmaceuticals has received final approval from the U.S. FDA for its generic methotrexate injection. 这种用于治疗癌症和自身免疫性疾病的药物将有两种强度和瓶式. The drug, used to treat cancers and autoimmune conditions, will be available in two strengths and vial formats. 这项批准扩大了该公司的产品组合,并可能改善患者获得负担得起的治疗. This approval expands the company's portfolio and may improve patient access to affordable treatments.